Ifp Advisors, Inc Alaunos Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$0.46 - $0.81 $4,379 - $7,711	-9,520 Reduced 55.16%	7,738 $4,000
Q4 2022 Feb 07, 2023	BUY	$0.5 - $261.0 $1,734 - $905,409	3,469 Added 25.16%	17,258 $84,000
Q3 2022 Nov 08, 2022	BUY	$1.04 - $322.5 $4,439 - $1.38 Million	4,269 Added 44.84%	13,789 $67,000
Q2 2022 Sep 06, 2022	BUY	$0.41 - $1.24 $3,903 - $11,804	9,520 New	9,520 $46,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $3,903 - $11,804	-9,520 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.62 - $1.17 $5,902 - $11,138	9,520 New	9,520 $6,000
Q4 2021 Jan 12, 2022	SELL	$1.09 - $1.89 $214 - $372	-197 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$1.44 - $2.73 $283 - $537	197 New	197 $1,000
Q2 2021 Jul 13, 2021	SELL	$2.63 - $3.67 $2,630 - $3,670	-1,000 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$2.82 - $5.6 $2,820 - $5,600	1,000 New	1,000 $4,000
Q4 2020 Jan 25, 2021	BUY	$2.09 - $3.09 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$2.39 - $3.43 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$2.2 - $3.71 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$1.9 - $4.98 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$3.95 - $5.35 $14,753 - $19,982	-3,735 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$4.13 - $6.94 $15,425 - $25,920	3,735 New	3,735 $16,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $240 - $528	-120 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$1.61 - $3.62 $4,131 - $9,288	-2,566 Reduced 95.53%	120 $0
Q3 2018 Oct 25, 2018	SELL	$2.26 - $3.27 $338 - $490	-150 Reduced 5.29%	2,686 $0
Q2 2018 Aug 07, 2018	BUY	$3.02 - $4.94 $694 - $1,136	230 Added 8.83%	2,836 $0
Q1 2018 Jun 03, 2019	SELL	$3.46 - $5.14 $304 - $452	-88 Reduced 3.27%	2,606 $11,000
Q1 2018 May 09, 2018	BUY	$3.46 - $5.14 $304 - $452	88 Added 3.38%	2,694 $0
Q3 2017 Oct 30, 2017	SELL	$4.99 - $6.57 $6,487 - $8,541	-1,300 Reduced 33.28%	2,606 $16,000
Q1 2017 Jun 03, 2019	SELL	N/A	-200 Reduced 4.87%	3,906 $25,000
Q4 2016 Jun 03, 2019	SELL	N/A	-2,100 Reduced 33.84%	4,106 $22,000
Q2 2016 Jun 03, 2019	BUY	N/A	6,206	6,206 $34,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account